249 related articles for article (PubMed ID: 22229571)
1. Progress in gene and cell therapy for cystic fibrosis lung disease.
Griesenbach U; Alton EW
Curr Pharm Des; 2012; 18(5):642-62. PubMed ID: 22229571
[TBL] [Abstract][Full Text] [Related]
2. Current status and future directions of gene and cell therapy for cystic fibrosis.
Griesenbach U; Alton EW
BioDrugs; 2011 Apr; 25(2):77-88. PubMed ID: 21443272
[TBL] [Abstract][Full Text] [Related]
3. Is gene therapy in cystic fibrosis a realistic expectation?
McElvaney NG
Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
[TBL] [Abstract][Full Text] [Related]
4. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
6. Non-viral approach toward gene therapy of cystic fibrosis lung disease.
Bragonzi A; Conese M
Curr Gene Ther; 2002 Sep; 2(3):295-305. PubMed ID: 12189717
[TBL] [Abstract][Full Text] [Related]
7. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.
Tang Y; Yan Z; Engelhardt JF
Hum Gene Ther; 2020 May; 31(9-10):524-537. PubMed ID: 32138545
[TBL] [Abstract][Full Text] [Related]
8. Toward cystic fibrosis gene therapy.
Wagner JA; Gardner P
Annu Rev Med; 1997; 48():203-16. PubMed ID: 9046956
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
Marquez Loza LI; Yuen EC; McCray PB
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
Copreni E; Penzo M; Carrabino S; Conese M
Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy in cystic fibrosis.
Armstrong DK; Cunningham S; Davies JC; Alton EW
Arch Dis Child; 2014 May; 99(5):465-8. PubMed ID: 24464978
[TBL] [Abstract][Full Text] [Related]
12. Emerging gene therapies for cystic fibrosis.
Miah KM; Hyde SC; Gill DR
Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
[No Abstract] [Full Text] [Related]
13. [On the way to gene therapy in cystic fibrosis].
Norek A; Bal J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
[TBL] [Abstract][Full Text] [Related]
14. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on gene therapy for cystic fibrosis airway disease.
Bigger B; Coutelle C
BioDrugs; 2001; 15(9):615-34. PubMed ID: 11580305
[TBL] [Abstract][Full Text] [Related]
16. Update on gene therapy for cystic fibrosis.
Griesenbach U; Geddes DM; Alton EW
Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
19. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
20. Moving forward: cystic fibrosis gene therapy.
Griesenbach U; Alton EW
Hum Mol Genet; 2013 Oct; 22(R1):R52-8. PubMed ID: 23918661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]